Registered entities
Magenta Therapeutics Inc
Reg. No. 810724163United States
Magenta Therapeutics, Inc.
Reg. No. 1690585United States
Innovation
56 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Emerging technologies; filing pace slowing. Cited 2,916 times.
| Year | Filings |
|---|---|
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 22 |
| 2020 | 38 |
| 2021 | 27 |
| 2022 | 32 |
| 2023 | 18 |
| 2024 | 9 |
| 2025 | 3 |
Investor mix
9 investors on record; lead investors include Google Ventures, Atlas Venture, Third Rock Ventures, Casdin Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Other / undisclosed | 4 | 44% |